Manufacturer Refunds to 340B Providers Have Steadily Increased Since 2019, Says Analysis

An analysis from the law firm Spencer Fane found that 340B refunds have been concentrated among certain manufacturers and drugs.
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals Raise Concerns on Biden Drug Shortage Proposal

HHS recently released a proposal to address drug shortages with measures focused on both hospitals and drug manufacturers.
While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Maryland, Kansas Send 340B Contract Pharmacy Access Bills to Their Governors

The Maryland legislature cleared a 340B contract pharmacy access bill the day after the Kansas legislature approved a state budget bill with similar 340B provisions.
The Maryland and Kansas legislatures have each cleared bills that would prohibit drug manufacturer 340B contract pharmacy restrictions in their [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mississippi Legislature Sends 340B Contract Pharmacy Protection Bill to The Governor

The Mississippi state house and senate have passed a bill to prohibit drugmaker 340B contract pharmacy restrictions.
The Mississippi state senate yesterday overwhelmingly cleared for the governor’s consideration a bill to prohibit drugmaker 340B contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Bill Targeting 340B In-Kind Funding Heads to Governor’s Desk

The Tennessee legislature cleared a bill, by state Rep. Esther Helton-Haynes (R), that tightens requirements for 340B in-kind funding for STD clinics.
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bridging the primary care gap: The role of in-house pharmacies in today’s healthcare marketplace

Holly Russo, Maxor 340B

SPONSORED CONTENT

Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients in convenient ways,

Read More »

340B Stakeholders Clash on Patient Definition, 340B Spending Requirements in Comments on Senate ‘Group of Six’ Draft Overhaul

Advocacy groups for providers and drugmakers had diverging views in their comments on a draft Senate 340B overhaul.
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals Say HRSA Violated Federal Rulemaking in 340B Child Site Waiver Reversal

More than 40 health systems told a federal district court that a HRSA hospital offsite clinic registration policy reversal violated federal rulemaking requirements.
The dozens of health systems suing the federal government over the reversal of a pandemic-era 340B child site registration waiver [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Officially Issues Contract Pharmacy Restrictions

Pharmaceutical manufacturer Genentech has formally implemented 340B contract pharmacy restrictions for hospitals.
Drugmaker Genentech has formally issued contract pharmacy restrictions after it gave some 340B hospitals advance notice last month of its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live